Skip to content

A Study on the Application of Liuzijue in Improving Left Ventricular Function and Quality of Life in Patients After Coronary Artery Bypass Graft Surgery

A Study on the Application of Liuzijue in Improving Left Ventricular Function and Quality of Life in Patients After Coronary Artery Bypass Graft Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116050
Enrollment
Unknown
Registered
2026-01-05
Start date
2026-01-05
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

After coronary artery bypass grafting

Interventions

Intervention group:On the basis of the control group's plan, the "Six-Character Formula" training was added
Control group:Receive conventional treatment, care and rehabilitation training

Sponsors

Beijing chaoyang integrative medicine rescue and first aid hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who have undergone CABG surgery, aged 45 to 80, have stable vital signs, are conscious, can cooperate with assessment and treatment, and sign the informed consent form

Exclusion criteria

Exclusion criteria: Abnormal mental state, inability to cooperate with treatment, unstable vital signs, and severe complications (cerebral hemorrhage, gastrointestinal bleeding, numbness of limbs, hemiplegia of limbs).

Design outcomes

Primary

MeasureTime frame
Left Ventricular Ejection Fraction (LVEF);Quality of Life Evaluation Form(SF-36);

Secondary

MeasureTime frame
Brain natriuretic peptide;

Countries

China

Contacts

Public ContactZhang Hong

Beijing chaoyang integrative medicine rescue and first aid hospital

18611320064@163.com+86 186 1132 0064

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026